Frank J. Marciniak

FDA investigator

Appears on 7 documents from 2018 to 2023, mostly at sites in New Jersey. Most often cites design controls (21 CFR 820.30).

7
Documents on file
4.9
Observations per 483
2018
First seen
2023
Most recent

What they cite most

From 34 observations

Activity by year

2018: 1, 2019: 2, 2021: 1, 2022: 1, 2023: 2

Where

New Jersey 6 · North Carolina 1

Is Frank J. Marciniak coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 Howmedica Osteonics CorpDec 1, 2023 · Mahwah, New Jersey
483 Navinta LLCJun 29, 2023 · Ewing, New Jersey
483 Alkaline CorporationAug 16, 2022 · Eatontown, New Jersey
483 Svelte Medical SystemsJun 14, 2021 · New Providence, New Jersey
483 Water-Jel Technologies, LLCAug 15, 2019 · Huntersville, North Carolina
483 LifeCell Corporation, A Wholly OwnedJun 14, 2019 · Branchburg, New Jersey
483 Datascope CorpOct 3, 2018 · Mahwah, New Jersey

About this profile

What does Frank J. Marciniak inspect?

Frank J. Marciniak appears on 7 documents on file covering 7 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 820.30 (design controls), followed by 21 CFR 820.100 and 21 CFR 820.75.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Frank J. Marciniak is dated Dec 1, 2023.